Baudax Bio Inc expected to post a loss of $2.35 a share - Earnings Preview

Baudax Bio

03/05/2022 19:31

* Baudax Bio Inc  BXRX.OQ   BXRX.O  is expected to show a
rise in
quarterly revenue when it reports  results on May 5. 
    * The Malvern Pennsylvania-based  company is expected to
report  a
343.7% increase in revenue to $878.5 thousand from $198 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Baudax Bio Inc is
for a
loss of $2.35 per share. For the same quarter last year, the
company reported a loss of $9.45 per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 280.6%
in the last three months. ​
    * Wall Street's median 12-month price target for Baudax Bio
Inc is
$7.5​, above​ its last closing price of $1.62. ​​​

This summary was machine generated May 3 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated